E
Eric P. Goosby
Researcher at National Institutes of Health
Publications - Â 8
Citations - Â 5172
Eric P. Goosby is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Medicine & Welfare. The author has an hindex of 4, co-authored 4 publications receiving 5158 citations.
Papers
More filters
Journal ArticleDOI
Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
Anthony S. Fauci,John G. Bartlett,Eric P. Goosby,M. D. Smith,H. J. Kaiser,S. W. Chang,James M. Anderson,R. Armstead,A. C. Baker,David A Barr,Samuel A. Bozzette,S. Cox,M. Delaney,Fred M. Gordin,W. Greaves,M. Harrington,J. J. Henning,Martin S. Hirsch,J. Jacobs,Richard Marlink,C. Maxwell,J. W. Mellors,D. B. Nash,S. Perryman,Robert T. Schooley,R. Sherer,Stephen A. Spector,G. Torres,Paul A. Volberding,B. A. Brady,E. M. Daniels,D. Feigal,Mark B. Feinberg,H. D. Gayle,T. R. Graydon,Jonathan E. Kaplan,Abe M. Macher,R. F. Martin,Henry Masur,Lynne M. Mofenson,J. Murray,J. O'Neill,L. C. Perez,R. Riseberg,S. Shekar,Sharilyn K. Stanley,J. Whitescarver +46 more
TL;DR: These Guidelines were developed by the Panel* on Clinical Practices for Treatment of HIV Infection convened by the Department of Health and Human Services and the Henry J. Kaiser Family Foundation.
Journal ArticleDOI
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002
Henry Masur,Jonathan E. Kaplan,King K. Holmes,Beverly Alston,Miriam J. Alter,Neil M. Ampel,Jean Anderson,A. Cornelius Baker,David A Barr,John G. Bartlett,John E. Bennett,Constance A. Benson,William A. Bower,Samuel A. Bozzette,John T. Brooks,Victoria A. Cargill,Kenneth G. Castro,Richard E. Chaisson,David A. Cooper,Clyde S. Crumpacker,Judith S. Currier,Kevin M. DeCock,Lawrence Deyton,Scott F. Dowell,W. Lawrence Drew,William Duncan,Mark S. Dworkin,Clare A. Dykewicz,Robert W Eisinger,Tedd Ellerbrock,Wafaa El-Sadr,Judith Feinberg,Kenneth A. Freedberg,Keiji Fukuda,Hansjakob Furrer,Jose M. Gatell,John W. Gnann,Mark J. Goldberger,Sue Goldie,Eric P. Goosby,Fred M. Gordin,Peter A. Gross,Rana Hajjeh,Richard Hafner,Diane Havlir,S D Holmberg,David R. Holtgrave,Thomas M. Hooton,Douglas A. Jabs,Mark A. Jacobson,Harold Jaffe,Edward N. Janoff,Jeffrey M. Jones,Dennis D. Juranek,Mari M. Kitahata,Joseph A. Kovacs,Catherine Leport,Myron J. Levin,Juan C. Lopez,Jens D Lundgren,Michael Marco,Eric Mast,Douglas L. Mayers,Lynne M. Mofenson,Julio Montaner,Richard A. Moore,Thomas Navin,James D. Neaton,Charles Nelson,Joseph F. O'Neill,Joel Palefsky,Alice Pau,Phil Pellett,John P. Phair,Steve Piscitelli,Michael A. Polis,Thomas C. Quinn,William C. Reeves,Peter Reiss,David Rimland,Anne Schuchat,Cynthia L. Sears,Leonard B. Seeff,Kent A. Sepkowitz,Kenneth E. Sherman,Thomas G. Slama,Elaine M. Sloand,Stephen A. Spector,John A. Stewart,David L. Thomas,Timothy M. Uyeki,Russell Van Dyke,M. Elsa Villarino,Anna Wald,D. Heather Watts,L. Joseph Wheat,Paige L. Williams,Thomas C. Wright +97 more
TL;DR: This fourth edition of the guidelines for preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV) is intended for clinicians and other health-care providers who care for HIV-infected persons.
Journal Article
1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus
Henry Masur,Jonathan E. Kaplan,King K. Holmes,Beverly Alston,Neil M. Ampel,Jean Anderson,A. Cornelius,David A Barr,John Bartlett,John E. Bennett,Sam Bozzette,Richard E. Chaisson,Judith S. Currier,Lawrence Deyton,Lawrence W. Drew,William Duncan,Robert P. Eisinger,Kenneth A. Freedberg,Hansjakob Furrer,Mark J. Goldberger,Sue J. Goldie,Eric P. Goosby,Richard Hafner,Diane V. Havlir,Douglas A. Jabs,Mark A. Jacobson,Mari M. Kitahata,Joseph A. Kovacs,Catherine Leport,Claude Bernard,Juan C. Lopez +30 more
TL;DR: In August 1999, agencies of the U.S. Public Health Service (USPHS), in collaboration with the Infectious Diseases Society of American (IDSA), published 1999 Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus (HIV).
U.S. Public Health Service Task Force Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States
Jean Anderson,Rebecca Denison,I. Celine Hanson,R. Maupin,Howard Minkoff,Gwendolyn B. Scott,Steven Spector,Ruth Tuomala,Nancy A. Wade,Patrician Whitley-Williams,Catherine M. Wilfert,Elizabeth Glaser,Carmen Zorrilla,Lynne M. Mofenson,D. Heather Watts,Mary Glenn Fowler,Martha Rogers,Magda Barini-Garcia,Lydia Soto-Torres,Melisse Baylor,Eric P. Goosby,Margaret Scarlett,Deborah von Zinkernagel,Carolyn K Burr,Elaine Gross,Cheryl Thiemann +25 more
TL;DR: These recommendations update the 1994 guidelines developed by the Public Health Service for the use of zidovudine (ZDV) to reduce the risk for perinatal human immunodeficiency virus type 1 (HIV-1) transmission.
Journal ArticleDOI
Assessing the impact of one million COVID-19 deaths in America: economic and life expectancy losses
TL;DR: In this paper , the authors estimated that US life expectancy at birth dropped by 3.08 years due to the million COVID-19 deaths between February 2020 and May 2022, and the combined impact on national income growth and the added value of lives lost was in the order of US$3.57 trillion.